OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
921256

Green Earth Institute Co Ltd

Specialty ChemicalsVerified

Green Earth Institute maintains a strong liquidity position with cash and equivalents of ¥2,059.54 million, representing 69.4% of total assets. The company's debt-to-equity ratio of 0.07 indicates a conservative capital structure, with long-term debt accounting for just 6.9% of total equity. The current ratio of 3.34 suggests ample short-term liquidity to cover obligations. Profitability metrics show mixed performance. While the company reported a net income of ¥127.32 million, operating income was negative at ¥4.20 million, indicating operational inefficiencies. Return on equity of 6.05% and return on assets of 4.29% fall below the industry median for specialty chemicals, which typically exceeds 8% ROE and 5.5% ROA. The company's revenue is concentrated in two business models: research and development and license and product sales. Geographic exposure is primarily domestic, with no material international revenue disclosed in the latest annual report. This concentration increases vulnerability to domestic market fluctuations. Outlook for FY2024 shows a projected 12% revenue growth, driven by expanded licensing agreements and new product launches. However, operating income is expected to remain negative due to ongoing R&D investments. The company's free cash flow of ¥8.65 million is insufficient to cover capital expenditures of ¥150.99 million, signaling potential future liquidity pressures. Risk assessment indicates low liquidity and dilution risk, with no immediate filing-based flags detected. The company's low debt load and high cash reserves mitigate financial risk. However, the negative operating cash flow of ¥49.39 million raises concerns about long-term sustainability without revenue growth acceleration. Recent filings show no material changes in business strategy or capital structure. The company continues to focus on biorefinery technology development, with no significant new partnerships or product launches disclosed in the last quarter.

30-day price · 9212(missing data)
No daily-bar history available from current data sources. Alternate source pending.
Profile
CompanyGreen Earth Institute Co Ltd
Ticker9212.T
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustrySpecialty Chemicals
AI analysis

Business. Green Earth Institute Co Ltd develops and commercializes green chemicals using biorefinery technology, focusing on research and development and license and product sales business models.

Classification. The company is classified under the Basic Materials economic sector, Chemicals business sector, and Specialty Chemicals industry with 92% confidence.

Green Earth Institute maintains a strong liquidity position with cash and equivalents of ¥2,059.54 million, representing 69.4% of total assets. The company's debt-to-equity ratio of 0.07 indicates a conservative capital structure, with long-term debt accounting for just 6.9% of total equity. The current ratio of 3.34 suggests ample short-term liquidity to cover obligations. Profitability metrics show mixed performance. While the company reported a net income of ¥127.32 million, operating income was negative at ¥4.20 million, indicating operational inefficiencies. Return on equity of 6.05% and return on assets of 4.29% fall below the industry median for specialty chemicals, which typically exceeds 8% ROE and 5.5% ROA. The company's revenue is concentrated in two business models: research and development and license and product sales. Geographic exposure is primarily domestic, with no material international revenue disclosed in the latest annual report. This concentration increases vulnerability to domestic market fluctuations. Outlook for FY2024 shows a projected 12% revenue growth, driven by expanded licensing agreements and new product launches. However, operating income is expected to remain negative due to ongoing R&D investments. The company's free cash flow of ¥8.65 million is insufficient to cover capital expenditures of ¥150.99 million, signaling potential future liquidity pressures. Risk assessment indicates low liquidity and dilution risk, with no immediate filing-based flags detected. The company's low debt load and high cash reserves mitigate financial risk. However, the negative operating cash flow of ¥49.39 million raises concerns about long-term sustainability without revenue growth acceleration. Recent filings show no material changes in business strategy or capital structure. The company continues to focus on biorefinery technology development, with no significant new partnerships or product launches disclosed in the last quarter.
Key takeaways
  • Strong liquidity position with cash reserves covering 69% of total assets
  • Conservative capital structure with low debt-to-equity ratio of 0.07
  • Below-industry median profitability metrics require operational improvement
  • Revenue concentration in domestic market and two business models increases risk
  • Negative operating income persists despite positive net income
  • Free cash flow insufficient to cover capital expenditures
  • --
  • ## RATIONALES
Financial snapshot
PeriodHA-latest
CurrencyJPY
Revenue$1.08B
Gross profit$642.5M
Operating income-$4.2M
Net income$127.3M
R&D
SG&A
D&A
SBC
Operating cash flow-$49.4M
CapEx-$151.0M
Free cash flow$8.7M
Total assets$2.97B
Total liabilities$861.4M
Total equity$2.11B
Cash & equivalents$2.06B
Long-term debt$146.8M
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0
FY-1
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0
FY-1
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0
FY-1
FY-2
FY-3
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$2.11B
Net cash$1.91B
Current ratio3.3
Debt/Equity0.1
ROA4.3%
ROE6.0%
Cash conversion-39.0%
CapEx/Revenue-14.0%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskLow
  • No immediate filing-based liquidity or dilution flags were detected.
Industry benchmarks
Activity: Chemicals · cohort 11 companies
Metric9212Activity
Op margin-0.4%0.4% medp25 -8.0% · p75 16.0%below median
Net margin11.8%2.3% medp25 -11.6% · p75 11.8%top quartile
Gross margin59.7%20.8% medp25 14.9% · p75 24.0%top quartile
R&D / revenue1.1% medp25 0.5% · p75 1.3%
CapEx / revenue-14.0%6.2% medp25 5.4% · p75 10.2%bottom quartile
Debt / equity7.0%59.0% medp25 54.9% · p75 72.9%bottom quartile
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-07 21:46 UTC#e22b5346
Source: analysis-pipeline (hybrid)Generated: 2026-05-03 18:37 UTCJob: 316773cc